Back
Royalty Pharma PLC Vs. Novavax Industry Stock Comparison
Sell
27
RPRX
Royalty Pharma PLC
Last Price:
26.41
Seasonality Move:
3.06%
Sell
28
NVAX
Novavax
Last Price:
8.47
Seasonality Move:
18.22%
Sell
27
Royalty Pharma PLC (RPRX)
is a Sell
Is Royalty Pharma PLC a Buy, Sell or Hold?
- The current Royalty Pharma PLC [RPRX] share price is $26.43. The Score for RPRX is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
- RPRX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
28
Novavax (NVAX)
is a Sell
Is Novavax a Buy, Sell or Hold?
- The current Novavax [NVAX] share price is $8.47. The Score for NVAX is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
- NVAX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
RPRX Stock Price Chart
What is Royalty Pharma PLC's stock price today?
-
The Royalty Pharma PLC share price today is $26.43
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RPRX is experiencing slight selling pressure.
RPRX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.36 | Sell |
| Relative Strength Index (14 RSI): | 45.67 | Sell |
| Chaikin Money Flow: | -820430 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (26.05 - 27.31) | Sell |
| Bollinger Bands (100): | (26.56 - 28.44) | Sell |
NVAX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.82 | Sell |
| Relative Strength Index (14 RSI): | 41.69 | Sell |
| Chaikin Money Flow: | 2253927 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (8.07 - 9.91) | Sell |
| Bollinger Bands (100): | (9.74 - 14.06) | Sell |
RPRX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 26 | Buy |
| 20-day SMA: | 26.51 | Sell |
| 50-day SMA: | 27.29 | Sell |
| 200-day SMA: | 28.02 | Sell |
| 8-day EMA: | 26.21 | Buy |
| 20-day EMA: | 26.48 | Sell |
| 50-day EMA: | 27.03 | Sell |
| 200-day EMA: | 27.96 | Sell |
NVAX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 7.84 | Buy |
| 20-day SMA: | 8.75 | Sell |
| 50-day SMA: | 10.87 | Sell |
| 200-day SMA: | 10.1 | Sell |
| 8-day EMA: | 8.16 | Buy |
| 20-day EMA: | 8.79 | Sell |
| 50-day EMA: | 10.17 | Sell |
| 200-day EMA: | 10.63 | Sell |
Royalty Pharma PLC Earnings Growth & RPRX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.13 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.30 per share, and an increase next year of $0.31 per share.
Novavax Earnings Growth & NVAX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.35 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.39 per share, and an increase next year of $2.35 per share.
Royalty Pharma PLC Technical Analysis
| Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Novavax Technical Analysis
| Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||